Lexeo Therapeutics LXEO
NASDAQ LXEO
$3.53 -0.09 (-2.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexeo Therapeutics (LXEO) Interest & Investment Income (2022 - 2026)

Updated

Lexeo Therapeutics' Interest & Investment Income came in at $2.19 million for Q2 2026, up 73.0% from $1.27 million a year earlier and up 3.8% from the prior quarter.

Analysis

Lexeo Therapeutics (LXEO) Interest & Investment Income (2022 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Lexeo Therapeutics reported Interest & Investment Income of $7.98 million, up 32.5% year-over-year; for FY2025, it was $6.13 million, down 18.9% from FY2024.

  • Interest & Investment Income carries a three-year compound annual growth rate of 66.6% (FY2022 to FY2025).
  • Going back by year, Interest & Investment Income was $7.56 million in FY2024 (+163.6%), $2.87 million in FY2023 (+116.4%) and $1.33 million in FY2022.
  • The five-year range for quarterly Interest & Investment Income is $456,000 (Q3 2022) to $2.35 million (Q2 2024).
  • Year-over-year, Interest & Investment Income has increased for three consecutive quarters, with growth averaging 57.3% over the last eight quarters.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q3 2024 (growth of 328.7%), and the weakest in Q2 2025 (a decline of 46.0%).
  • Business Quant data shows LXEO's Interest & Investment Income at $2.11 million (Q1 2026), $2.21 million (Q4 2025) and $1.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Lexeo Therapeutics 277.54 Mn 277.54 Mn - 2.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.19 Mn
Mar 31, 2026 2.11 Mn
Dec 31, 2025 2.21 Mn
Sep 30, 2025 1.46 Mn
Jun 30, 2025 1.27 Mn
Mar 31, 2025 1.19 Mn
Dec 31, 2024 1.47 Mn
Sep 30, 2024 2.09 Mn
Jun 30, 2024 2.35 Mn
Mar 31, 2024 1.65 Mn
Dec 31, 2023 1.10 Mn
Sep 30, 2023 488,000.00
Jun 30, 2023 590,000.00
Mar 31, 2023 687,000.00
Dec 31, 2022 676,000.00
Sep 30, 2022 456,000.00
API Access

Lexeo Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LXEO&period=max&api_key=YOUR_API_KEY